Financials
- Market Capitalization 207.36 M
- Employee 229
- Founded 1999
- CEO André Choulika
- Website www.cellectis.com
- Headquarter France
- FIGI BBG0084L1XN2
- Industry Biotechnologie
Gesamtumsatz
Jahresüberschuss
Gesamtverschuldung
Freier Cashflow
Zahlungsmittel und Zahlungsmitteläquivalente
Related tickers
| # | Name | Preis | 24h % | 7d % | 1M % | 1J % | Marktkapitalisierung | Letzte 7 Tage | |
|---|---|---|---|---|---|---|---|---|---|
| 3589 | NBP NovaBridge Biosciences - American Depositary Shares | 1.86 USD | -2.11% | -7.46% | +25.68% | -58.76% | 214.61 M USD | ||
| 3603 | RNA Atrium Therapeutics, Inc. - Common Stock | 12.22 USD | -1.93% | -7.00% | -1.45% | -82.62% | 209.03 M USD | ||
| 3613 | SLGL Sol-Gel Technologies Ltd. - Ordinary Shares | 73.91 USD | -0.05% | +0.03% | +1.25% | +833.21% | 205.92 M USD | ||
| 3616 | CDXS Codexis, Inc. - Common Stock | 2.25 USD | -7.41% | -14.45% | -9.27% | -27.18% | 204.52 M USD |